KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Equity Ratio: 2009-2024

Historic Equity Ratio for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 0.14.

  • Teva Pharmaceutical Industries' Equity Ratio rose 19.07% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year increase of 19.07%. This contributed to the annual value of 0.14 for FY2024, which is 26.80% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Equity Ratio stood at 0.14 for FY2024, which was down 26.80% from 0.19 recorded in FY2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Equity Ratio peaked at 0.24 during FY2021, and registered a low of 0.14 during FY2024.
  • Moreover, its 3-year median value for Equity Ratio was 0.19 (2023), whereas its average is 0.17.
  • In the last 5 years, Teva Pharmaceutical Industries' Equity Ratio climbed by 8.00% in 2021 and then dropped by 26.80% in 2024.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Equity Ratio stood at 0.22 in 2020, then climbed by 8.00% to 0.24 in 2021, then fell by 17.18% to 0.20 in 2022, then decreased by 4.33% to 0.19 in 2023, then dropped by 26.80% to 0.14 in 2024.